Antibody–drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment

Antibody–drug conjugates (ADCs) are a class of antineoplastic agents whose structure is composed of three main components: a monoclonal antibody (mAB) targeting a specific target antigen, a cytotoxic payload, and a linker binding the antibody to the payload. By combining the specificity of mABs with...

Descripción completa

Detalles Bibliográficos
Autores principales: Nader-Marta, Guilherme, Molinelli, Chiara, Debien, Véronique, Martins-Branco, Diogo, Aftimos, Philippe, de Azambuja, Evandro, Awada, Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331351/
https://www.ncbi.nlm.nih.gov/pubmed/37435563
http://dx.doi.org/10.1177/17588359231183679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331351/
https://www.ncbi.nlm.nih.gov/pubmed/37435563
http://dx.doi.org/10.1177/17588359231183679

Ejemplares similares